All News

It isn't always so "normal," is it?

Older patients with acute myeloid leukemia (AML) often face a difficult choice: risky, intensive chemotherapy that offers a small chance of a cure versus non-intensive chemotherapy meant to improve physical comfort and quality of life.

Specifically, the study demonstrated that patients with advanced cancer prefer that their physicians speak with them while holding a note pad, rather than while typing into computers that link to electronic health records.

Patients and their caregivers saw physical and emotional improvements after starting yoga.

Targeted intervention is effective in improving psychosocial stress experienced by many adolescent and young adult (AYA) patients with cancer, according to a study released ahead of the 2017 Palliative and Supportive Care in Oncology Symposium to be held Oct. 27-28 in San Diego.

The combination of Tafinlar (dabrafenib) and Mekinist (trametinib) was granted a breakthrough therapy designation by the Food and Drug Administration (FDA) for the adjuvant treatment of patients who have stage 3 melanoma and a BRAF V600 mutation, after they have already had a complete resection.

The largest ruling yet was overturned by a California judge on Oct. 20.

The combination of the immunotherapies Opdivo (nivolumab) and Yervoy (ipilimumab) sparked a response in nearly half of asymptomatic patients with melanoma brain metastases who had not received prior local therapy to the brain.

The longest response rate lasted six months.

A guy who knows breast cancer shares some surgical tips.

Although chemotherapy has been used to treat patients with Merkel cell carcinoma, immunotherapy agents show great promise, according to findings presented at the 2017 World Congress of Melanoma.

Cancer survivor notices difficulty with changes and transitions since cancer.

Prosthesis is another word added to my cancer vocabulary.

A cancer survivor describes her rocky road to learning a new art form to help her heal.

Research into metastasis is changing the future for all stages of breast cancer.

A survivor remembers as a pottery class sparks memories of her experiences with breast cancer.

It can be an awkward feeling when you all of a sudden go from almost weekly procedures to being cancer free.

Cobra, baseball cards and two guys who always let me know I wasn't dead.

Sometimes we can be regarded as being obsessed with cancer, but every single cancer survivor is more than that, and hold important roles in our lives to play.

Yescarta was granted FDA approval for use in adults with relapsed or refractory non-Hodgkin lymphoma. This is only the second CAR T-cell therapy ever approved.

Members of the public can submit comments to the U.S. Preventive Services Task Force (USPSTF) on its draft recommendation statement on sun protection until Nov. 6, 2017.

Opdivo (nivolumab) was granted a priority review to a supplemental biologics license application (sBLA) to treat patients with melanoma who have a high risk of disease recurrence after complete surgical resection, according to Bristol-Myers Squibb (BMS), the company that makes the drug.

Genetics may play a role in chemotherapy-related fatigue, according to a recent study.

Breast cancer always leaves scars. Some are visible and some are not. Today, I'd like to focus on the visible scars.

Cancer is a serious disease, but approaching life with a lighter and happier attitude will help cancer survivors.

If cancer hadn't happened to me, what would I be like? Have you ever asked yourself that?

Overall survival (OS) was improved when patients with advanced liver cancer took Cabometyx (cabozantinib), compared to those who were given placebo. All participants previously took Nexavar (sorafenib).

The origin of that pink ribbon may surprise you.